Pharmaceutical products

Tender description

Hospital only products — all regions: 1 February 2021 to 31 January 2022 Orals (plus non-parenterals) – all regions: 1 March 2021 to 28 February 2022 12 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. NHS National Generic Pharmaceuticals Interim 2 2020 Offer reference number: CM/PHG/20/5619 Period of framework agreement: 12 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months OJEU Reference number: [insert OJEU Reference number] Potential periods of call-offs under the framework agreement: Hospital only products — all regions: 1 February 2021 to 31 January 2022 Orals (plus non-parenterals) – All regions: 1 March 2021 to 28 February 2022. NHS National Generic Pharmaceuticals Interim 2 2020 Offer reference number: CM/PHG/20/5619 Period of framework agreement: 12 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months potential periods of call-offs under the framework agreement: Hospital only products — all regions: 1 February 2021 to 31 January 2022 Orals (plus non-parenterals) – All regions: 1 March 2021 to 28 February 2022.